Challenges of modern day transition care in inflammatory bowel disease: From inflammatory bowel disease to biosimilars

World J Gastroenterol. 2017 Jul 7;23(25):4473-4479. doi: 10.3748/wjg.v23.i25.4473.

Abstract

In this article we discuss the challenges of delivering a high quality Transition care. A good understanding of the adolescent needs with good communication between Transition care physicians and the patient is essential for good continuity of care. Despite availability of several guidelines, one model doesn't fit all and any transition service development should be determined by the local need and available healthcare facilities.

Keywords: Adolescent; Biosimilar; Inflammatory bowel disease; Transition.

Publication types

  • Editorial

MeSH terms

  • Adolescent
  • Biosimilar Pharmaceuticals / therapeutic use*
  • Communication
  • Gastroenterologists / psychology*
  • Gastroenterologists / standards
  • Humans
  • Inflammatory Bowel Diseases / drug therapy*
  • Physician-Patient Relations
  • Practice Guidelines as Topic
  • Quality of Health Care*
  • Transition to Adult Care / standards*

Substances

  • Biosimilar Pharmaceuticals